Dr. Martin B. Leon Joined Scientific Advisory Board

Jun 28, 2017

Storrs CT, June 28, 2017 – Dura Biotech (“Dura Biotech” or the “Company”) a privately held pre-clinical stage medical device company today announced that Martin B. Leon, MD has joined its scientific advisory board.


Martin B. Leon, MD is Professor of Medicine at Columbia University Medical Center (CUMC). Dr. Leon is also Director of the Center for Interventional Vascular Therapy (CIVT), Director of the Cardiac Catheterization Laboratories, and on the Executive Board of the Columbia NewYork-Presbyterian Heart Valve Center. He continues as a practicing Interventional cardiologist at NewYork-Presbyterian Hospital in New York City. Dr. Leon is also the Founder and Chairman Emeritus of the Cardiovascular Research Foundation.

Sutra Preclinical Animal Studies

July 2019

  • Successful transseptal deployment of Sutra TMVR in an acute animal study.

September 2018 – January 2019

  • Animals survived at 120 and 150-day endpoints.

October 2016

  • Short-term feasibility demonstrated in animal model,
  • No interference with LVOT or subannular apparatus,
  • Good coaptation between the prosthetic leaflets and the native anterior leaflet.